Medscape9h
GLP-1s Show No Increased Risk for Thyroid Cancer
In a large population of people with diabetes, the use of GLP-1 receptor agonists was not linked to an increased risk for ...
Hosted on MSN2d
Perioperative GLP-1 RA Use Reduces Risk for Complications in Patients With Diabetes
For patients with diabetes undergoing a surgical procedure, an active perioperative glucagon-like peptide-1 receptor agonist ...
Medscape6d
Are Patients On GLP-1s Getting the Right Nutrients?
As GLP-1 RA use soars, experts are worried that patients may not be getting the right nutrients in their diets. How can ...
healthday2d
Perioperative GLP-1 RA Use Reduces Risk for Complications in Patients With Diabetes
MONDAY, Jan. 13, 2025 (HealthDay News) -- For patients with diabetes undergoing a surgical procedure, an active perioperative glucagon-like peptide-1 receptor agonist (GLP-1 RA) prescription is ...
Zacks.com on MSN1d
LLY Stock Down on Lower-Than-Expected Sales Guidance for Q4
LLY's shares slip more than 6% as it cuts outlook for 2024 sales. Preliminary fourth-quarter revenues fall short of estimates ...
C&EN1d
Verdiva smashes European biotech financing record
The series A fundraising is the biggest ever for a European biotech firm, according to the data provider PitchBook.
Study finds no elevated risk of thyroid cancer among GLP1-RA users
A study has found no evidence that glucagon-like peptide 1 receptor agonist (GLP1-RA) use is associated with an increased ...
Cardinal Health forecasts annual profit at higher end of prior range
Cardinal Health said on Tuesday it expects annual profit to be at the higher end of its previous forecast range, primarily ...